「」JCH:HDV重叠感染可增加慢性乙型肝炎患者的肝细胞癌风险( 三 )


参考文献:
[1]Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study[J]. Lancet Gastroenterol Hepatol, 2018, 3(6): 383-403.
[2]FLORES R, RUIZ-RUIZ S, SERRA P. Viroids and hepatitis delta virus[J]. Semin Liver Dis, 2012, 32(3): 201-210.
[3]SHIRVANI-DASTGERDI E, TACKE F. Molecular interactions between hepatitis B virus and delta virus[J]. World J Virol, 2015, 4(2): 36-41.
[4]D?NY P. Hepatitis delta virus genetic variability: From genotypes I, II, III to eight major clades?[J]. Curr Top Microbiol Immunol, 2006, 307: 151-171.
[5]GAETA GB, STROFFOLINI T, CHIARAMONTE M, et al. Chronic hepatitis D: A vanishing disease? An Italian multicenter study[J]. Hepatology, 2000, 32(4 Pt 1): 824-827.
[6]HEIDRICH B, DETERDING K, TILLMANN HL, et al. Virological and clinical characteristics of delta hepatitis in Central Europe[J]. J Viral Hepat, 2009, 16(12): 883-894.
[7]PATEL EU, THIO CL, BOON D, et al. Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016[J]. Clin Infect Dis, 2019, 69(4): 709-712.
[8]RIZZETTO M, CIANCIO A. Epidemiology of hepatitis D [J]. Semin Liver Dis, 2012, 32(3): 211-219.
[9]HAO LJ, LI L, ZHANG YY, et al. Hepatitis D virus infection in liver tissues of patients with hepatitis B in China[J]. Chin Med J (Engl), 1992, 105(3): 204-208.
[10]HUO TI, WU JC, LAI CR, et al. Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection[J]. J Hepatol, 1996, 25(4): 439-444.
[11]CROSS TJ, RIZZI P, HORNER M, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London[J]. J Med Virol, 2008, 80(2): 277-282.
[12]TOUKAN AU, ABU-EL-RUB OA, ABU-LABAN SA, et al. The epidemiology and clinical outcome of hepatitis D virus (delta) infection in Jordan[J]. Hepatology, 1987, 7(6): 1340-1345.
[13]TAMURA I, KURIMURA O, KODA T, et al. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: A study from Kure, Japan[J]. J Gastroenterol Hepatol, 1993, 8(5): 433-436.
[14]FATTOVICH G, GIUSTINA G, CHRISTENSEN E, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)[J]. Gut, 2000, 46(3): 420-426.
[15]UZUNALIMOGˇLU O, YURDAYDIN C, CETINKAYA H, et al. Risk factors for hepatocellular carcinoma in Turkey[J]. Dig Dis Sci, 2001, 46(5): 1022-1028.
[16]DEGˇERTEKIN H, YAL?IN K, YAKUT M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies[J]. Turk J Gastroenterol, 2006, 17(1): 25-34.
[17]ROMEO R, DEL NINNO E, RUMI M, et al. A 28-year study of the course of hepatitis delta infection: A risk factor for cirrhosis and hepatocellular carcinoma[J]. Gastroenterology, 2009, 136(5): 1629-1638.


推荐阅读